eczema Archives - Drugs in Context

Dermatology: how to manage atopic dermatitis in patients with skin of colour

Muskaan Sachdeva, Marissa Joseph

Article Type

Review

Published

31 May 2022

In this narrative review, the authors discuss differences in the epidemiology, pathophysiology, clinical presentation and treatment of atopic dermatitis in skin of colour.

Emerging systemic JAK inhibitors in the treatment of atopic dermatitis: a review of abrocitinib, baricitinib, and upadacitinib

Novin Nezamololama, BSc, MSc, Keira Fieldhouse, BSc, Kristy Metzger, BSc, Melinda Gooderham, MD, MSc, FRCPC

Article Type

Review

Published

16 Nov 2020

This review summarizes the clinical data available from various trials and reports on the safety and efficacy of abrocitinib, baricitinib, and upadacitinib, the three oral systemic JAK inhibitors used in the treatment of atopic dermatitis.

Dismissing the fallacies of childhood eczema management: case scenarios and an overview of best practices

Kam Lun Hon MBBS, MD (CUHK), FAAP, FCCM, Kin Fon Leong MBBS, MRCPCH, Theresa Leung MBBS, FRCPCH, FHKAM(Paed), FHKCPaed, Alexander KC Leung MBBS, FRCPC, FRCP(UK & Irel), FRCPCH, FAAP

Article Type

Review

Published

10 Oct 2018

AD is often complicated and difficult to manage in many Asian cities and effective therapy is impeded by fallacies. In this article eleven anonymized case scenarios are described to illustrate issues associated with these fallacies. A literature review is performed and possible solutions to handle or dismiss these fallacies are discussed.

Atopic dermatitis: a review of topical nonsteroid therapy

Ariana Papier BA, Lindsay C Strowd MD

Article Type

Review

Published

04 Apr 2018

This review focuses on the safety and efficacy of topical calcineurin and PDE4 inhibitors for the treatment of atopic dermatitis.